DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis


Tan-Chiu E, Yothers G, Romond E. et al.
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.

J Clin Oncol 2005;
23 (31) 7811-7819

Download Bibliographical Data